SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (621)12/20/1997 6:30:00 PM
From: Andrew H   of 887
 
Yeah, biao's post cleared it up for me as well. Its an unfortunate situation, John. I would want to hear more info from the company before I bought this stock even at these low prices. Like were there really communication difficulties between the FDA and the ODAC committee? Why was the company not aware that the patients they considered inevaluable would be considered evaluable by the comittee? Etc. The company should have been fully aware of these things, especially since they had such a small sample size in their treatment group.

To me it looks like more than a simple "failure to communicate." It looks like management incompetence. I would hesitate to invest in a company whose management I did not respect at any price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News